when was semaglutide approved by fda Approves Oral for Weight Loss Early uptake of Wegovy pill

We're treating these medications as standalone solutions rather than tools within a comprehensive metabolic health program

Unlock lasting weight loss with Calibrate's clinically-led Metabolic Reset

Yale researchers have discovered that GLP-1 receptor agonist drugs, like Ozempic and Wegovy, may offer promising new ways of treating alcohol use disorder.

Laboratory-grade, third-party tested, lyophilized, and intended for research use only.

That's not the trade high-performing executives should make

* * * To learn more about the obesity opportunity, please read our obesity deep dive, part of our recent white paper on the broader renaissance of cardiometabolic innovation